Literature DB >> 11788373

Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs.

Chang An Chu1, Stephanie M Sherck, Kayano Igawa, Dana K Sindelar, Doss W Neal, Maya Emshwiller, Alan D Cherrington.   

Abstract

The aim of this study was to determine the effect of high levels of free fatty acids (FFA) and/or hyperglycemia on hepatic glycogenolysis and gluconeogenesis. Intralipid was infused peripherally in 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence (FFA + HG) or absence (FFA + EuG) of hyperglycemia. In the control studies, Intralipid was not infused, and euglycemia (EuG) or hyperglycemia (HG) was maintained. Insulin and glucagon were clamped at basal levels in all four groups. The arterial blood glucose level increased by 50% in the HG and FFA + HG groups. It did not change in the EuG and FFA + EuG groups. Arterial plasma FFA increased by approximately 140% in the FFA + EuG and FFA + HG groups but did not change significantly either in the EuG or HG groups. Arterial glycerol levels increased by approximately 150% in both groups. Overall (3-h) net hepatic glycogenolysis was 196 +/- 26 mg/kg in the EuG group. It decreased by 96 +/- 20, 82 +/- 16, and 177 +/- 22 mg/kg in the HG, FFA + EuG, and FFA + HG groups, respectively. Overall (3-h) hepatic gluconeogenic flux was 128 +/- 22 mg/kg in the EuG group, but it was suppressed by 30 +/- 9 mg/kg in response to hyperglycemia. It was increased by 59 +/- 12 and 56 +/- 10 mg/kg in the FFA + EuG and FFA + HG groups, respectively. In conclusion, an increase in plasma FFA and glycerol significantly inhibited hepatic glycogenolysis and markedly stimulated hepatic gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788373     DOI: 10.1152/ajpendo.00136.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  17 in total

1.  Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.

Authors:  P Iozzo; R Lautamaki; F Geisler; K A Virtanen; V Oikonen; M Haaparanta; H Yki-Jarvinen; E Ferrannini; J Knuuti; P Nuutila
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

Review 2.  Central nervous system and control of endogenous glucose production.

Authors:  Giovanna Demuro; Silvana Obici
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 3.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

4.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

5.  Hepatic glucose uptake and disposition during short-term high-fat vs. high-fructose feeding.

Authors:  Katie C Coate; Guillaume Kraft; Mary Courtney Moore; Marta S Smith; Christopher Ramnanan; Jose M Irimia; Peter J Roach; Ben Farmer; Doss W Neal; Phil Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-27       Impact factor: 4.310

6.  Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.

Authors:  Simon J Fisher; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 7.  Fat-induced liver insulin resistance.

Authors:  Pankaj Shah; Ananda Basu; Robert Rizza
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

8.  Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability.

Authors:  Sheng-Song Chen; Tammy S Santomango; Phillip E Williams; D Brooks Lacy; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-10       Impact factor: 4.310

9.  Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production.

Authors:  Haiming Cao; Motohiro Sekiya; Meric Erikci Ertunc; M Furkan Burak; Jared R Mayers; Ariel White; Karen Inouye; Lisa M Rickey; Baris C Ercal; Masato Furuhashi; Gürol Tuncman; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.